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PURPOSE: To characterize the different components of metabolic acidosis in patients with hyperlactatemia in order to determine
the degree to which lactate is responsible for the acidosis and the relevance that this might have in the outcome of these patients.
METHODS: Arterial blood gas, arterial lactate, Na+, K+, Ca2+, Mg2+, Cl-, phosphate, albumin, and creatinine were measured on
admission to make a diagnosis of the acid-base disturbances present. Intensive Care Unit and in-hospital mortality were also
recorded.
RESULTS: A total of 58 patients with hyperlactatemia were included. They usually had a mild acidemia (pH 7.31 ± 0.12) and a
significantly high Standard Base Deficit (7.6 ± 6.7 mEq/L). In addition to lactate (4.3 ± 2.3 mEq/L), chloride (106.9 ± 9.5 mEq/L)
and unmeasured anions (8.6 ± 5.0 mEq/L) accounted for the metabolic acidosis. Unmeasured anions were primarily responsible
for the acidosis in both Intensive Care Unit survivors and nonsurvivors (44.7% ± 26.0% and 46.0% ± 17.5%, respectively, P =
0.871). Lactate contributed in similar percentages to the acidosis in both groups (23.0% ± 11.8% and 24.2% ± 9.7% in Intensive
Care Unit survivors and nonsurvivors, respectively; P = 0.753). Correlation between Standard Base Deficit and lactate was found
only in Intensive Care Unit nonsurvivors (r = 0.662, P < 0.01).
DISCUSSION: Hyperlactatemia is usually accompanied by metabolic acidemia, but lactate is responsible for a minor percentage
of the acidosis; unmeasured anions account for most of the acidosis in patients with hyperlactatemia. The percentage of the
acidosis due to hyperlactatemia was not relevant in terms of outcome.
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INTRODUCTION
Since the first definition of hyperlactatemia and lactic
acidosis proposed by Huckabee in 1961,1 many controver-
sies have occurred and different definitions have been pro-
posed in order to determine and separate distinct situations
that lead to an altered lactate metabolism. Initially, the
terms “hyperlactatemia” or “stress hyperlactatemia” were
used for situations in which no concomitant metabolic aci-
dosis (at that time defined as low levels of serum bicarbo-
nate) was present. Increases in serum lactate attributed to
an enhanced aerobic glycolytic pathway with a normal
pyruvate/lactate ratio were thought to account for the cases
of hyperlactatemia without acidosis.
When acidemia and low levels of serum bicarbonate
were also present, the term “lactic acidosis” was then used.
This condition could occur in the absence or in the pres-
ence of tissue hypoperfusion, and physical exam would de-
termine whether there were or were not signs of
hemodynamic compromise and circulatory shock.
In 1976, Cohen and Woods2 abolished the term
“hyperlactatemia without acidosis” and classified altered
lactate metabolism into lactic acidosis types A and B, us-
ing the same previous criteria of presence or absence of
tissue dysoxia.
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More recently, the physicochemical approach to acid-
base disturbances 3 has supported the idea that there is no
reason to separate “hyperlactatemia” and “lactic acidosis”
since lactate, as a strong anion, is an acid itself. This mod-
ern approach has the great advantage of characterizing the
different components of the complex and usually multifac-
torial metabolic acidosis of critically ill patients.
Standard base deficit (SBD) is frequently used to quan-
tify the degree of metabolic acidosis, and it seems to be a
better parameter than bicarbonate, which is highly influ-
enced by the level of pCO2 and, therefore, by respiratory
disturbances. Some authors have defined lactic acidosis as
an SBD greater than 2 mEq/L with a lactate component
that comprises at least 50% of the SBD.4
The aim of this study was to evaluate the SBD and its
components in the presence of hyperlactatemia on admis-
sion to the intensive care unit (ICU) using the physico-
chemical approach and to determine to what degree
hyperlactatemia was responsible for changes in the SBD.
We hypothesized that in a significant number of patients
with hyperlactatemia, lactate would not be the major anion
responsible for metabolic acidosis and, additionally, that
some patients with hyperlactatemia would not actually have
metabolic acidosis (defined as an SBD ≥ 2 mEq/L). We also
determined whether the percentage of the SBD due to
hyperlactatemia was relevant in terms of outcome. Because
lactic acidosis seems to be the metabolic acidosis with the
poorest prognosis,4 it is possible that both the absolute lev-
els of lactate and the degree to which lactate contributes
to the final SBD are important.
MATERIALS AND METHODS
This study was approved by the local institutional eth-
ics committee. Since all data used here was collected in
the process of routine exams performed for all patients that
are admitted to our ICU, the requirement for informed writ-
ten consent was waived.
It is the routine in our 7-bed medical ICU to collect a
list of laboratory tests from all patients on admission. This
list includes an arterial blood gas determination with si-
multaneous arterial lactate measurement, Na+, K+, Ca2+,
Mg2+, Cl-, phosphate, urea, creatinine, and albumin. From
July 2005 until January 2006, all consecutive patients ad-
mitted to the ICU and their admission blood gas samples
were checked prospectively for hyperlactatemia, defined as
an arterial lactate ≥ 2 mEq/L. Patients transferred from or
to a different ICU were excluded. In patients with
hyperlactatemia, we evaluated the simultaneous arterial pH,
standard base deficit (SBD), partial pressure of carbon di-
oxide (pCO2), bicarbonate (HCO3-), lactate, Na+, K+, Ca2+,
Mg2+, Cl-, phosphate, albumin, and creatinine, and we cal-
culated the 4 distinct components of SBD, the apparent
strong ion difference (SIDa), the effective strong ion dif-
ference (SIDe), and the strong ion gap (SIG) (see below).
Age, gender, APACHE II score, ICU mortality, and in-hos-
pital mortality were also recorded for all patients with
hyperlactatemia.
Laboratory techniques and measurements
All biochemical variables were simultaneously collected
at the time of admission to the ICU. All samples were
analyzed in the central laboratory of the Institution. Na+,
K+, Ca2+, and Cl- were measured with the use of a direct
ion-selective electrode technique, Mg2+ by a colorimetric
technique, and phosphate with the use of an ultraviolet tech-
nique. Albumin was measured with a bromocresol dye
colorimetric technique. Arterial blood gas was analyzed and
lactate was measured on the OMNI analyzer (Roche Di-
agnostics System, F. Hoffmann-La Roche Ltd, Basel, Swit-
zerland).
Quantitative physicochemical analysis
According to the contemporary approach to acid-base
disturbances proposed by Stewart 3 and then modified by
Figge et al,5 only 3 independent variables can change the
blood pH: the strong ion difference (SID), weak acids
(mainly phosphate and albumin), and pCO2. Based on the
principles of electroneutrality and conservation of mass, the
strong ion difference represents the net balance between
positive strong ions (cations) and negative strong ions (ani-
ons) according to the following formula (all concentrations
in mEq/L):
SID = (Na+ + K+ + Ca2+ + Mg2+) – (Cl- + lactate-)
Therefore, decreases in the strong ion difference (such
as those occurring in hyperchloremia and hyperlactatemia)
lead to increases in dissociation of water (to maintain
electroneutrality) and a fall in the pH. The opposite hap-
pens if the strong ion difference increases. This equation,
however, does not take into account the weak acids present
in blood; therefore, we call this the apparent strong ion dif-
ference (SIDa). The effective strong ion difference (SIDe)
is represented by the sum of the charges of the weak acids
according to the following equation:
SIDe = [(2.46 x 10-8)*(pCO2 (mm Hg)/(10-pH))] + [(albumin
(g/L) * (0.123 x pH – 0.631)] + [(phosphate (mmol/L)) *
(0.309 x pH – 0.469)]
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In healthy people, no significant amounts of unmeasured
anions or lactate are present in the blood. The values of
apparent and effective strong ion difference are therefore
very close. However, in critically ill patients, both lactate
and unmeasured ions are likely to increase. Unmeasured
anions, measured by the strong ion gap (SIG), represent the
“gap” between apparent and effective strong ion difference
as shown in the following formula:
SIG = SIDa – SIDe
In summary, metabolic acidosis, according to the physi-
cochemical theory, can only be the result of decreases in
apparent strong ion difference (mainly hyperchloremia and
hyperlactatemia), increases in the strong ion gap
(unmeasured anions), or increases in weak acids
(hyperalbuminemia, which is exceedingly rare, and
hyperphosphatemia).
The final result of alkalinizing and acidifying distur-
bances present in the blood is represented by the SBD,
which is the titrable acid in blood,6 being positive when
acidifying disturbances predominate and negative when al-
kalinizing disturbances are more prevalent. Using a physi-
cochemical analysis, we can separate 4 distinct components
of the SBD7 as follows:
• standard base deficit due to free water (SBDfw), which
depends on the concentration of Na+:
SBDfw = 0.3 x (140 – Na+ (mEq/L))
• standard base deficit due to chloride (SBDcl), which de-
pends on the concentration of both Na+ and Cl-:
SBDcl = (Cl+ (mEq/L) x (140/Na+ (mEq/L)) – 102
• standard base deficit due to albumin (SBDalb), which
depends on the arterial pH and the concentration of se-
rum albumin:
SBDalb = ((0.148 x pH) – 0.818) x (albumin (g/L) – 45)
• standard base deficit due to lactate and unmeasured ani-
ons (SBDua), which corresponds to the rest of the SBD:
SBDua = SBD – (SBDfw + SBDcl + SBDalb)
Although there is no consensus about a precise value
of the SBD that represents significant metabolic acidosis,
we decided to use an arbitrary value of 2 mEq/L, since
hypoalbuminemia is an almost universal finding in criti-
cally ill patients, contributing a mean value of -5 mEq/L
in the final SBD in a recent study.8 Therefore, even a small
positive SBD value, such as 2 mEq/L, could be the conse-
quence of a significant acidifying disturbance.
To calculate the percentage of metabolic acidosis due
to hyperlactatemia, we considered the total acidifying ele-
ments (SBD acid) as the following (all concentrations in
mEq/L):
SBD acid = [lactate] + SBDfw + SBDcl + SIG
We did not use the SBDua in the formula, since it does
not discriminate between lactate and unmeasured anions;
we preferred to use the strong ion gap,9 as the equivalent
of the unmeasured anions, and lactate, separately. Since
hypoalbuminemia is almost invariably present in critically
ill patients, SBDalb was not included in the formula (it al-
most always has an alkalinizing effect). SBDfw and SBDcl
were only included in the formula when their sum was posi-
tive, ie, when they had an acidifying effect.
The percentage of metabolic acidosis due to lactate (%
lactate) and due to the SIG (%SIG) were then determined
by the following relationships:
%lactate = lactate / SBD acid
%SIG = SIG / SBD acid
The rest of the metabolic acidosis (not due to lactate
or the SIG) was attributed mainly to hyperchloremia.
Statistical analysis
All values were expressed as mean and standard devia-
tion except for 2 variables (Ca2+ and creatinine), which re-
quired a logarithmic transformation in order to acquire a
normal distribution. Their values were expressed as geo-
metric means. The Student t test was used for comparison
of continuous parameters, and Pearson’s test was used for
the correlation analysis. The software SigmaStat for Win-
dows (version 2.0, Copyrightãð Jandel Corporation) and
SPSS for Windows (version 10.0.1, Copyrightãð SPSS In-
corporation) were used for all measurements. A P value less
than 0.05 was considered significant.
RESULTS
During the study period, 159 patients were admitted into
our ICU, and 152 patients were included in the study; 7
patients were excluded because they came from another
ICU or were transferred to another ICU before discharge.
Of the 152 patients, we found lactate ≥ 2 mEq/L in 58 pa-
tients (38.2%) at admission. The general characteristics of
this group of patients are shown in Table 1. Using the physi-
58
CLINICS 2007;62(1):55-62Unmeasured anions account for most of the metabolic acidosis in patients with hyperlactatemia
Maciel AT et al.
cochemical approach to analyze the different components
of the acid-base disturbances present in these patients (Ta-
ble 2), we verified that they usually exhibited a mild
acidemia (pH 7.31 ± 0.12) and a significant metabolic aci-
dosis (SBD 7.6 ± 6.7 mEq/L). This metabolic acidosis was
due to both hyperlactatemia (lactate 4.3 ± 2.3 mEq/L) and
hyperchloremia (chloride 107 ± 10 mEq/L), both of which
contributed to a decreased apparent strong ion difference
(36.3 ± 6.5 mEq/L), and to an increased strong ion gap (8.6
± 5.0 mEq/L). Serum levels of Na+, K+, Ca2+, Mg2+, and
phosphate were normal, and low levels of serum albumin
(26 ± 8 g/L) attenuated the level of metabolic acidemia.
Creatinine was already increased at admission (1.4 ± 2.4
mg/dL). Lactate was 23.3% ± 11.2% of the SBD acid, and
the SIG was 45.1% ± 23.9% (P < 0.001) (Figure 1). A sig-
nificant correlation was found between SBD and lactate (r
= 0.322, P = 0.01).
We divided the patients grouping into ICU survivors and
nonsurvivors, and we then evaluated the same variables de-
scribed above (Table 3). Both groups were usually acidemic
on admission, but nonsurvivors had a tendency to be more
acidemic (pH 7.33 ± 0.10 vs 7.26 ± 0.15, P = 0.05). Meta-
bolic acidosis was more severe in nonsurvivors (SBD 11.7
± 7.3 mEq/L vs 6.1 ± 5.8 mEq/L in survivors, P< 0.01).
The same acidifying variables—hyperlactatemia,
hyperchloremia, and increased strong ion gap—contributed
to metabolic acidosis in both groups. Of these, only lac-
tate was significantly higher in nonsurvivors (3.8 ± 1.8 vs
5.8 ± 2.9 mEq/L, P < 0.01). However, as occurred in the
analysis of all patients with hyperlactatemia (Table 2), both
survivors and nonsurvivors had a minority of their meta-
bolic acidosis due to lactate. Lactate comprised 23.0% ±
11.8% of the SBD acid in survivors and 24.2% ± 9.7% in
nonsurvivors (P = 0.753). The SIG comprised 44.7% ±
26.0% of the SBD acid in survivors and 46.0% ± 17.5%
in nonsurvivors (P = 0.871). The percentage of SBD acid
Table 2 - Biochemical variables of the 58 patients with
hyperlactatemia (lactate ≥ 2 mEq/L) (mean ± SD)
Variable Value (n = 58)
pH 7.31 ± 0.12
pCO2 - mm Hg 35.6 ± 14.3
HCO3- - mEq/L 17.7 ± 6.2
SBD* - mEq/L 7.6 ± 6.7
Lactate - mEq/L 4.3 ± 2.3
Na+ - mEq/L 140 ± 7
K+ - mEq/L 4.3 ± 0.9
Ca2+ a - mEq/L 2.3 ± 1.2
Mg2+ - mEq/L 1.0 ± 0.3
Cl- - mEq/L 107 ± 10
Phosphate - mmol/L 1.4 ± 0.5




 - mEq/L 36.3 ± 6.5
SID
e
 - mEq/L 27.2 ± 6.4
SIGc - mEq/L 8.6 ± 5.0
Creatininea - mg/dL 1.4 ± 2.4
SBDfw - mEq/L 0.0 ± 2.0
SBDCl - mEq/L 4.8 ± 6.7
SBD
alb - mEq/L -5.0 ± 2.2
SBD
ua
 - mEq/L 7.4 ± 5.9
* SBD = standard base deficit, the respective following abbreviations; denote:
FW - free water portion of SBD, Cl - chloride portion of SBD, alb - albumin
portion of SBD and ua - unmeasured anions portion of SBD; ageometric
mean and standard deviation; bSID = strong ion difference, and the
abbreviations denote: a - apparent SID and e - effective SID; cSIG denotes
strong ion gap
Table 1 - General characteristics of the 58 patients with
hyperlactatemia (lactate ≥ 2 mEq/L)
Characteristic Value (n = 58)
Age – years (mean ± SD) 54 ± 19
Gender - male/female – no. (%)* 30 (52) / 28 (48)
APACHE II scorea (mean ± SD) 16 ± 8
ICUb mortality – no. (%) 16 (28)
Hospital mortality – no. (%) 25 (43)
Diagnosis
Severe sepsis / septic shock – no. (%) 19 (33)
Post-operative – no. (%) 12 (21)
Respiratory failure – no. (%) 11 (19)
Trauma – no. (%) 5 (9)
Neurologic syndromesc – no. (%) 4 (7)
Pancreatitis – no. (%) 2 (3)
Cardiogenic shock – no. (%) 1 (2)
Other – no. (%) 4 (7)
*no. = the number of patients with the characteristic. aAPACHE II = the
acute physiologic and chronic health evaluation score, which ranges from 0
to 72. bICU = intensive care unit. cneurologic syndromes including stroke
and meningoencephalitis
Figure 1 - Percentage of metabolic acidosis due to lactate and the strong ion
gap (SIG). Metabolic acidosis was mainly due to the SIG in all groups; the
percentage due to lactate was significantly lower than that due to the SIG in
all groups (P < 0.001). Regarding ICU survivors and nonsurvivors, no
difference was found in the percentage of metabolic acidosis due to lactate
(P = 0.753) or due to the SIG (P = 0.871).
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due to the strong ion gap was significantly greater than the
percentage due to lactate in both survivors and nonsurvivors
(P < 0.001 for both groups) (Figure 1). All electrolytes were
similar in both groups, as was creatinine. Hypoalbuminemia
was present in both groups but was greater in nonsurvivors
(2.1 ± 0.5 g/dL) than in survivors (2.8 ± 0.8 g/dL) (P <
0.01). Correlation between SBD and lactate was absent in
survivors (r = -0.125, P = 0.430) and present in
nonsurvivors (r = 0.662, P < 0.01).
Eight of the 58 patients with hyperlactatemia (13.8%) did
not have metabolic acidosis (ie, an SBD > 2 mEq/L). Only
1 died in the ICU. Of the 58 patients with hyperlactatemia,
7 (12.1%) had lactate levels greater than the strong ion gap
on admission. All survived until discharge from ICU.
DISCUSSION
Hyperlactatemia is a well established marker of poor
outcome in critically ill patients.10–13 However, interpreta-
tion of high levels of lactate is a challenge to intensivists,
since its etiology and pathophysiology is not always clear.
Until recently, it was common to use the terms
“hyperlactatemia” and “lactic acidosis” interchangeably
and as synonyms of “tissue hypoperfusion;” however, this
is not always the case.14 Although we have shown in our
study that patients with hyperlactatemia usually presented
with metabolic acidemia, and that at admission, both lac-
tate and the SBD were significantly different between ICU
survivors and nonsurvivors, lactate was not primarily re-
sponsible for the acidemia; it was rather, the unmeasured
anions that were primarily responsible. The etiology and
pathophysiology of increased levels of unmeasured anions
is even more obscure than that of hyperlactatemia. They
are thought to increase in many distinct situations such as
renal and hepatic impairment,15 tissue hypoperfusion,16 and
endotoxemia.17
Controversy exists regarding the relevance that
unmeasured anions have in the outcome of critically ill pa-
tients.18–20 In our study, the strong ion gap was not differ-
ent between survivors and nonsurvivors at admission, but
this could have been due to the small sample size. In a
larger study, Cusack et al18 also failed to find a significant
difference in the strong ion gap between survivors and
nonsurvivors. Similarly to our study, they found a relevant
difference in the SBDua between survivors and
nonsurvivors. Although both the strong ion gap and SBDua
are variables used to quantify unmeasured anions, SBDua
includes lactate and the strong ion gap does not. This could
explain the fact that in both studies, SBDua was different
in survivors vs nonsurvivors, while the strong ion gap was
not. Kellum suggested that the use of gelatins as resusci-
tation fluids may interfere in the prognostic relevance of
unmeasured anions.21 Neither do our ICU, or our Emer-
gency Department use this type of colloid; rather, we use
crystalloids in the resuscitation of our patients and only
rarely colloids.
Table 3 - Comparison between survivors and nonsurvivors (mean ± SD)
Characteristic Survivors(n = 42) Nonsurvivors(n = 16) P value
Age - years 55 ± 20 54 ± 20 0.90
APACHE II 14 ± 7 22 ± 6 < 0.01
pH 7.33 ± 0.10 7.26 ± 0.15 0.05
pCO2 - mm Hg 37.4 ± 14.8 31.0 ± 12.3 0.13
HCO3- - mEq/L 19.1 ± 5.7 14.1 ± 6.1 < 0.01
SBD - mEq/L 6.1 ± 5.8 11.7 ± 7.3 < 0.01
Lactate - mEq/L 3.8 ± 1.8 5.8 ± 2.9 < 0.01
Na+ - mEq/L 140 ± 6 141 ± 8 0.43
K+ - mEq/L 4.2 ± 0.9 4.3 ± 1.0 0.79
Ca2+ a - mEq/L 2.3 ± 1.1 2.4 ± 1.3 0.48
Mg2+ - mEq/L 1.0 ± 0.3 1.0 ± 0.2 0.64
Cl- - mEq/L 106 ± 9 108 ± 7 0.39
phosphate - mmol/L 1.3 ± 0.5 1.5 ± 0.7 0.28




- mEq/L 37.3 ± 6.3 33.9 ± 6.6 0.09
SID
e
 - mEq/L 29.0 ± 5.9 22.2 ± 4.9 < 0.001
SIGc - mEq/L 7.9 ± 5.1 10.5 ± 4.0 0.11
Creatininea - mg/dL 1.4 ± 2.3 1.7 ± 2.5 0.45
SBDFW* - mEq/L 0.1 ± 1.8 -0.3 ± 2.4 0.43
SBDCl - mEq/L 4.2 ± 6.7 6.2 ± 6.7 0.32
SBD
alb - mEq/L -4.6 ± 2.3 -6.2 ± 1.4 0.02
SBD
ua
 - mEq/L 6.3 ± 5.3 10.7 ± 6.5 0.02
* SBD = standard base deficit, the respective following abbreviations denote: FW - free water portion of SBD, Cl - chloride portion of SBD, alb - albumin
portion of SBD and ua - unmeasured anions portion of SBD; ageometric mean and standard deviation; bSID = strong ion difference, and the abbreviations
denote: a - apparent SID and e - effective SID; cSIG = strong ion gap
60
CLINICS 2007;62(1):55-62Unmeasured anions account for most of the metabolic acidosis in patients with hyperlactatemia
Maciel AT et al.
We found unmeasured anions to be the most important
acidifying variable in patients with hyperlactatemia, even
greater than lactate itself. If we use the definition of lactic
acidosis proposed by Gunnerson et al4 (lactate accounting
for more than 50% of the metabolic acidosis), most of pa-
tients with hyperlactatemia actually did not have lactic aci-
dosis. Although these authors found lactate to be prima-
rily responsible for metabolic acidosis in more patients than
were unmeasured anions, they selected only patients with
suspected lactic acidosis with an SBD higher than 2 mEq/
L. We found 13.8% of the patients with hyperlactatemia
to have an SBD lower than 2 mEq/L. Additionally, in their
study, not all values were collected at the same time on
the day of admission, and they studied a distinct popula-
tion. This could explain at least in part the differences be-
tween their findings and ours.
Most studies in critically ill patients have found a poor
correlation between the SBD and lactate.22–24 This could be
explained by the fact that lactate only represents a small
percentage of the SBD in most patients, in agreement with
the finding of our study. On the other hand, we found that
although the percentage of metabolic acidosis due to lac-
tate was similar between survivors and nonsurvivors with
hyperlactatemia, a significant correlation between lactate
and the SBD was only present in nonsurvivors. The most
feasible explanation would be that nonsurvivors had higher
levels of lactate, which could have resulted in a correla-
tion between the two variables. However, we had previously
found a correlation between lactate and the SBD only in
ICU nonsurvivors even when comparing groups with simi-
lar levels of lactate.25 According to the theory of unreversed
ATP hydrolysis proposed by Zilva,26 hyperlactatemia in
anaerobic conditions is followed by metabolic acidosis due
to the accumulation of protons that were produced in the
glycolytic pathway but not used in the oxidative metabo-
lism. At that time, lactate was not considered an acid. How-
ever, if the Zilva theory is true, depending on the origin of
hyperlactatemia (aerobic or anaerobic), the same level of
lactate could lead to distinctly different degrees of meta-
bolic acidosis. It is probable that in the group of ICU
nonsurvivors, more patients had hyperlactatemia due to tis-
sue hypoperfusion and anaerobiosis. This could lead to the
presence of a significant correlation between lactate and
the SBD in only this group of patients.
Our study had some limitations. Since we used only a
specific group of critically ill patients (those presenting
hyperlactatemia at admission to the ICU) during a short
observation period, our sample size was small; some ab-
sence of difference between groups could be due to this
fact. We also had a heterogenous population of critically
ill patients, so it is not easy to arrive at conclusions regard-
ing any specific group of patients, such as for instance sep-
tic patients.
Although largely used to define metabolic acidosis, the
SBD is the sum of both acidifying and alkalinizing vari-
ables. Therefore, normal values for the SBD may result
when significant acidifying disturbances including
hyperlactatemia occur concomitantly with significant alka-
linizing disturbances such as hypoalbuminemia. We found
a small proportion of patients with hyperlactatemia hav-
ing normal or even low values for the SBD, and we used
the term “hyperlactatemia without acidosis” for these pa-
tients, but this may not be appropriate or may even be para-
doxical.
The fact is that current literature does not have very pre-
cise and accurate definitions for “metabolic acidosis” and
“lactic acidosis.” A large variability between definitions
makes the comparison between studies very difficult.
Gunnerson et al4 defined “lactic acidosis” as lactate ac-
counting for more than 50% of the SBD. However, they
did not clearly define how they calculated this percentage.
Since, as we have already noted, the SBD includes alkali-
nizing variables, it would be more appropriate to calculate
this percentage by selecting only the acidifying variables
(the SBD acid in our study). The use of the total SBD may
overestimate the percentage of acidosis due to lactate.
Finally, all the data in this study were limited to the
day of admission. Evolutive changes in lactate and the SBD
are certainly very important in the outcome of these pa-
tients. However, the aim of this study was to check for the
prevalence of anions other than lactate on admission of pa-
tients with hyperlactatemia and not to evaluate the evolu-
tion of these anions during ICU stay. Our findings show
that although very relevant in terms of prognosis, lactate
is only the tip of a much larger iceberg predominantly com-
prised of unmeasured anions.
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RESUMO
Maciel AT, Park M. Ânions não mensuráveis são
responsáveis pela maior parte da acidose metabólica de
pacientes com hiperlactatemia. Clinics. 2007;62(1):55-62.
OBJETIVO: Caracterizar os diferentes componentes da
acidose metabólica de pacientes com hiperlactatemia de
modo a verificar o quanto o lactato é responsável pela
acidose e a relevância que isso possa ter no prognóstico
desses pacientes.
MÉTODOS: Gasometria arterial com dosagem de lactato,
Na+, K+, Ca2+, Mg2+, Cl-, fosfato, albumina e creatinina
séricas foram coletados no momento da admissão para fazer
o diagnóstico dos possíveis distúrbios ácido-básicos
presentes. Mortalidade na UTI e mortalidade hospitalar
foram avaliadas.
RESULTADOS: Um total de 58 pacientes com
hiperlactatemia foram incluídos. Eles tinham na média uma
acidemia leve (pH 7.31 ± 0.12) e o déficit de base
significativamente elevado (7.6 ± 6.7 mEq/L). Além do
lactato (4.3 ± 2.3 mEq/L), o cloro (106.9 ± 9.5 mEq/L) e
os ânions não mensuráveis (8.6 ± 5.0 mEq/L) contribuíram
para a acidose metabólica. Os ânions não mensuráveis
foram responsáveis pela maior parcela da acidose tanto nos
pacientes que tiveram alta da UTI como nos que faleceram
(44.7 ± 26.0 % e 46.0 ± 17.5 %, respectivamente, p=
0.871). O lactato contribuiu em percentagens semelhantes
para a acidose em ambos os grupos (23.0 ± 11.8 % nos
sobreviventes e 24.2 ± 9.7 % nos óbitos, p= 0.753).
Correlação entre o déficit de base e o lactato somente foi
encontrada nos óbitos (r = 0.662, p < 0.01).
DISCUSSÃO: Hiperlactatemia é comumente acompanhada
de acidemia metabólica, porém o lactato corresponde a uma
parcela minoritária da acidose; ânions não mensuráveis
contribuem com a maior parte da carga ácida em pacientes
hiperlactatêmicos. O percentual da acidose devido à
hiperlactatemia não foi relevante em termos de prognóstico.
UNITERMOS: Hiperlactatemia. Acidose láctica. Ânions
não mensuráveis. Prognóstico. Pacientes críticos.
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